WT1-AS, WT1 antisense RNA, 51352

N. diseases: 71; N. variants: 16
Disease: Neoplasm, Residual ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0242596
Disease: Neoplasm, Residual
Neoplasm, Residual 		0.070 Biomarker phenotype BEFREE However, there exists a controversy that WT1 as a marker for minimal residual disease (MRD) monitoring in acute leukemias. 26221900 2015
CUI: C0242596
Disease: Neoplasm, Residual
Neoplasm, Residual 		0.070 Biomarker phenotype BEFREE Our study represents the largest series of patients evaluating WT1 as a marker of MRD in PBSC LK products using a completely standardized real-time WT1-reverse transcriptase-PCR based assay. 24954546 2014
CUI: C0242596
Disease: Neoplasm, Residual
Neoplasm, Residual 		0.070 Biomarker phenotype BEFREE WT1 as a universal marker for minimal residual disease detection and quantification in myeloid leukemias and in myelodysplastic syndrome. 15179007 2004
CUI: C0242596
Disease: Neoplasm, Residual
Neoplasm, Residual 		0.070 Biomarker phenotype BEFREE This study was designed to quantitatively measure WT-1 expression levels in patients with chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL) during follow-up and to clarify the value of WT-1 as a molecular marker in minimal residual disease monitoring. 15265366 2004
CUI: C0242596
Disease: Neoplasm, Residual
Neoplasm, Residual 		0.070 Biomarker phenotype BEFREE Utility of WT1 as a reliable tool for the detection of minimal residual disease in children with leukemia. 12007019 2002
CUI: C0242596
Disease: Neoplasm, Residual
Neoplasm, Residual 		0.070 Biomarker phenotype BEFREE Wilms tumor gene (WT1) as a new marker for the detection of minimal residual disease in leukemia. 9669676 1998
CUI: C0242596
Disease: Neoplasm, Residual
Neoplasm, Residual 		0.070 Biomarker phenotype BEFREE WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. 7949179 1994